Amgen Inc
Market cap $205.3B
$384.85
AMGN
$384.85
+0.28% today
Buy with €1M virtual cash · No real money
Amgen Inc (AMGN) is a publicly traded company listed on the XNAS. As of September 18, 2026, Invest's signal rates AMGN a Buy, with the stock up 40% over the past year. You can practice trading AMGN risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$205.3B
Volume
2.2M
52-wk High
$447.03
52-wk Low
$269.77
Day High
$385.60
Day Low
$378.51
P/E (TTM)
23.90
Revenue (TTM)
$38.1B
EPS (TTM)
$16.10
Performance
1M
-13.0%
6M
+10.0%
1Y
+40.1%
Invest signal · AMGN
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
AMGN overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +16.7%Revenue
$10BEPS (diluted)
$4.37 per shareLatest AMGN news
Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape
GlobeNewswire Inc. · 1d ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks Investment Research · 2d ago
4 Defensive Stocks to Take Refuge in as Consumer Sentiment Plummets
Zacks Investment Research · 3d ago
Immunotherapy Drugs Market 2026: Precision Medicine, Next-Generation Biologics and Expanding Cancer Indications Fuel Growth Opportunities
GlobeNewswire Inc. · 3d ago
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
Zacks Investment Research · 4d ago
About Amgen Inc
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019).
The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Employees
31,500
30-Day Win Rate · AMGN
12 days
12 days
Last 24 sessions
How to practice trading AMGN
- 1
Use the AMGN buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top AMGN traders on Invest
Full leaderboardFrequently asked questions
Is AMGN a good stock to buy right now?
As of September 18, 2026, Invest's signal rates AMGN a Buy, based on its price trend, valuation, and fundamentals (P/E around 23.9), with the stock up 40% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading AMGN risk-free first.
What is Amgen Inc's (AMGN) market cap?
Amgen Inc has a market capitalization of approximately $205.3B, on trailing-twelve-month revenue of about $38.1B.
How has AMGN stock performed?
AMGN is up 40% over the past year and up 10% over six months. Its 52-week range runs roughly from $269.77 to $447.03. Past performance doesn't predict future results.
How can I practice trading AMGN for free?
On Invest you get €1,000,000 in virtual cash and can buy AMGN at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare AMGN with peers